Annual Meeting of the International Society of Cancer Metabolism (ISCaM): Cancer Metabolism.

Avnet, Sofia;Baldini, Nicola;Brisson, Lucie;De Milito, Angelo;Sonveaux, Pierre;et.al.
(2018) Frontiers in Oncology — Vol. 8, p. 329 (2018)

Files

99FrontiersISCaM2017.pdf
  • Open Access
  • Adobe PDF
  • 250.51 KB
Download

Details

Authors
  • Avnet, Sofia
    Author
  • Baldini, Nicola
    Author
  • Brisson, Lucie
    Author
  • De Milito, Angelo
    Author
  • Sonveaux, PierreUCLouvain
    Author
Show more
Abstract
Tumors are metabolic entities wherein cancer cells adapt their metabolism to their oncogenic agenda and microenvironmental influences. Metabolically different cancer cell subpopulations collaborate to optimize nutrient delivery with respect to immediate bioenergetic and biosynthetic needs. They can also metabolically exploit host cells. These metabolic networks are directly linked with cancer progression, treatment, resistance, and relapse. Conversely, metabolic alterations in cancer are exploited for anticancer therapy, imaging, and stratification for personalized treatments. These topics were addressed at the 4th annual meeting of the International Society of Cancer Metabolism (ISCaM) in Bertinoro, Italy, on 19-21 October 2017.
Affiliations

Citations

  • APA
  • Chicago
  • FWB

Avnet, S., Baldini, N., Brisson, L., De Milito, A., Otto, A. M., Pastoreková, S., Porporato, P. E., Szabadkai, G., & Sonveaux, P. (2018). Annual Meeting of the International Society of Cancer Metabolism (ISCaM): Cancer Metabolism. Frontiers in Oncology, 8, 329. https://doi.org/10.3389/fonc.2018.00329 (Original work published 2018)